Your browser doesn't support javascript.
loading
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek, J J; Leibowitz, M T; Weinstein, S P; Rowe, E D; Mendel, C M; Levy, B; McMahon, F G; Mullican, W S; Toth, P D; Cutler, N R.
Affiliation
  • Sramek JJ; California Clinical Trials, Beverly Hills, CA 90211, USA.
J Hum Hypertens ; 16(1): 13-9, 2002 Jan.
Article in En | MEDLINE | ID: mdl-11840225
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Appetite Depressants / Blood Pressure / Weight Loss / Adrenergic beta-Antagonists / Cyclobutanes / Heart Rate / Hypertension / Obesity Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Hum Hypertens Journal subject: ANGIOLOGIA Year: 2002 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Appetite Depressants / Blood Pressure / Weight Loss / Adrenergic beta-Antagonists / Cyclobutanes / Heart Rate / Hypertension / Obesity Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Hum Hypertens Journal subject: ANGIOLOGIA Year: 2002 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido